Transplant selection may boost survival in bile duct cancer

For people facing a serious bile duct cancer near the liver, the choice between surgery and transplant can feel overwhelming. This review of past studies compared two paths: a protocol to select patients for liver transplant versus standard liver resection. It found that the transplant approach was linked to higher 5-year survival and better disease-free survival. The analysis looked at 768 patients with this cancer, and it found no significant difference in short-term death rates after surgery. But the story comes with important caveats. The studies were retrospective, meaning they looked back in time, and they had significant selection bias. Also, transplant reports often focus on people who got the transplant, not everyone who was considered, which can make the benefits look bigger than they are. Safety data were not reported in these studies, so we do not know about side effects or complications.